Canopy Growth (CGC)
(Delayed Data from NSDQ)
$4.86 USD
+0.27 (5.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.86 USD
+0.27 (5.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Zacks News
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $15.76, marking a +0.13% move from the previous day.
Constellation Brands (STZ) Tops Q4 Earnings & Sales Estimates
by Zacks Equity Research
Constellation Brands (STZ) reports strong fourth-quarter fiscal 2020 results, driven by continued strength in the beer business and gains in the wine & spirits segment.
The Zacks Analyst Blog Highlights: UBER, ZM, MSFT, STZ and CGC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UBER, ZM, MSFT, STZ and CGC
Booze Takes The Edge Off The Coronavirus
by Daniel Laboe
Alcohol sales are flying this month and online delivery services are a primary catalyst
Buy Corona Maker Constellation (STZ) Stock Before Q4 Earnings Amid Surge?
by Benjamin Rains
Constellation Brands (STZ) shares have surged 40% in the last week. So now might be time for investors to consider buying the Corona beer maker's stock before it reports its Q4 fiscal 2020 results on Friday, April 3...
Are Marijuana Stocks & ETFs Coronavirus-Proof?
by Sanghamitra Saha
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
Do Options Traders Know Something About Canopy Growth (CGC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
Here's How Coronavirus Can Impact Cannabis Industry
by Zacks Equity Research
Marijuana should be avoided during the pandemic as users share marijuana joints, which may increase the spread of the virus.
Marijuana is Growing Cash, Can We Get In?
by Panel Of Zacks Experts
The market is still dealing with COVID19 (coronavirus issues) so we're talking about how marijuana is still a market mystery, Marijuana Innovators Editor Dave Borun joins us to shed some light on the subject.
How Canopy Growth (CGC) Stock Stands Out in a Strong Industry?
by Zacks Equity Research
Canopy Growth (CGC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
What Do Canopy Earnings Say About Cannabis ETFs?
by Sanghamitra Saha
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
Are Options Traders Betting on a Big Move in Canopy Growth (CGC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DexCom's (DXCM) fourth-quarter earnings are likely to reflect top-line growth and rising global awareness of the company's real-time CGM.
Cannabis Therapy to Drive Canopy Growth's (CGC) Q3 Earnings
by Zacks Equity Research
Key acquisitions are expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal third quarter
Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $22.33, marking a +1% move from the previous day.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $23.52 in the latest trading session, marking a -1.67% move from the prior day.
What's in Store for Pot Stocks This Year?
by Nitish Marwah
Increasing tolerance, financial protection, credit availability and legal votes have shaped America's hemp industry lately.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $24.56 in the latest trading session, marking a +1.82% move from the prior day.
Implied Volatility Surging for Canopy Growth (CGC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
Constellation Brands (STZ) Beats on Q3 Earnings, Ups View
by Zacks Equity Research
Constellation Brands' (STZ) top and bottom lines beat estimates in third-quarter fiscal 2020 on strength in the beer business and improved margins. It raises earnings and cash flow guidance.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $19.80, marking a -1.39% move from the previous day.
Canopy Growth Corporation (CGC) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $19.20, marking a -0.1% move from the previous day.
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
by Sanghamitra Saha
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
5 Cheap Stocks Trading Under $20 to Buy for 2020
by Benjamin Rains
Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...